Pragmatic Comparison of Piperacillin/Tazobactam versus Carbapenems in Treating Patients with Nosocomial Pneumonia Caused by Extended-Spectrum β-Lactamase-Producing <i>Klebsiella pneumoniae</i>

• Hoofdauteurs: Lei Zha (Auteur), Xiang Li (Auteur), Zhichu Ren (Auteur), Dayan Zhang (Auteur), Yi Zou (Auteur), Lingling Pan (Auteur), Shirong Li (Auteur), Shanghua Chen (Auteur), Boris Tefsen (Auteur)
• Formaat: Boek
• Gepubliceerd in: MDPI AG, 2022-10-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

The effectiveness of piperacillin/tazobactam for managing nosocomial pneumonia caused by extended-spectrum β-lactamase (ESBL)-producing <i>Enterobacteriaceae</i> is unknown. To answer this question, we conducted a retrospective cohort study in two tertiary teaching hospitals of patients...